Market Overview

Exelixis Shares Indicated Up ~4% Premarket Amid Recent Pharma M&A, Following Co. Report Tues. Afternoon an Update on CABOzantinib Will Be Presented at ESMO '16 Congress on Oct. 10, '16

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Movers

 

Related Articles (EXEL)